LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
191,700
+4,400 (2.35%)
At close: Feb 27, 2026
Market Cap6.98T +65.5%
Revenue (ttm)159.27B +57.0%
Net Income-25.13B
EPS-690.95
Shares Out36.41M
PE Ration/a
Forward PE457.09
Dividendn/a
Ex-Dividend Daten/a
Volume360,988
Average Volume436,484
Open187,300
Previous Close187,300
Day's Range186,000 - 194,200
52-Week Range89,500 - 221,500
Beta0.73
RSI58.76
Earnings DateMar 20, 2026

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 170
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements